• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人A431细胞上尿激酶原受体的自分泌饱和

Autocrine saturation of pro-urokinase receptors on human A431 cells.

作者信息

Stoppelli M P, Tacchetti C, Cubellis M V, Corti A, Hearing V J, Cassani G, Appella E, Blasi F

出版信息

Cell. 1986 Jun 6;45(5):675-84. doi: 10.1016/0092-8674(86)90782-8.

DOI:10.1016/0092-8674(86)90782-8
PMID:3011276
Abstract

Single-chain pro-urokinase (pro-uPA) is present both in the medium and lysate of the A431 epidermoid carcinoma cell line. Most of the cell-associated pro-uPA is on the cell surface, as shown by indirect immunofluorescence and by surface iodination. Pro-uPA is not an integral membrane protein but is bound to a specific surface receptor that is completely saturated. A mild acid treatment uncovers the surface receptors by dissociating pro-uPA. Resaturation of uncovered receptors has been studied by reincubating cells in normal medium; within 40 min, 50% of the free sites are reoccupied. Excess uPA-specific antibodies prevent rebinding of ligand to the receptors. Thus, A431 cells first secrete uPA, which then binds to the surface receptor. We propose that the synthesis of uPA and uPA receptor by the same cell may provide a pathway for the activation of the metastatic potential of malignant cells.

摘要

单链尿激酶原(pro - uPA)存在于A431表皮癌细胞系的培养基和裂解物中。如间接免疫荧光和表面碘化所示,大多数与细胞相关的pro - uPA位于细胞表面。Pro - uPA不是整合膜蛋白,而是与完全饱和的特定表面受体结合。温和的酸处理通过解离pro - uPA来暴露表面受体。通过在正常培养基中使细胞再孵育来研究未被覆盖受体的再饱和;在40分钟内,50%的游离位点被重新占据。过量的uPA特异性抗体可阻止配体与受体的重新结合。因此,A431细胞首先分泌uPA,然后uPA与表面受体结合。我们提出,同一细胞合成uPA和uPA受体可能为激活恶性细胞的转移潜能提供一条途径。

相似文献

1
Autocrine saturation of pro-urokinase receptors on human A431 cells.人A431细胞上尿激酶原受体的自分泌饱和
Cell. 1986 Jun 6;45(5):675-84. doi: 10.1016/0092-8674(86)90782-8.
2
Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.表皮生长因子对人鳞状细胞癌质膜相关尿激酶型纤溶酶原激活剂的调控
Cancer Commun. 1990;2(9):317-24.
3
Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).相互的尿激酶原/纤溶酶原激活动力学——由与聚(D-赖氨酸)结合的尿激酶受体形成的模板所刺激
Eur J Biochem. 1997 Apr 15;245(2):316-23. doi: 10.1111/j.1432-1033.1997.00316.x.
4
Characterization of the cellular binding site for the urokinase-type plasminogen activator.尿激酶型纤溶酶原激活剂细胞结合位点的特性分析
J Biol Chem. 1989 Jan 15;264(2):1180-9.
5
Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.人尿激酶原在丝氨酸138/303位点的磷酸化会损害其依赖受体促进骨髓单核细胞黏附和运动的能力。
J Cell Biol. 1997 May 5;137(3):779-91. doi: 10.1083/jcb.137.3.779.
6
Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.受体介导的纤溶酶原激活物功能调节:两种直接膜锚定形式的尿激酶对纤溶酶原的激活作用
J Pept Sci. 2000 Sep;6(9):432-9. doi: 10.1002/1099-1387(200009)6:9<432::AID-PSC279>3.0.CO;2-Q.
7
The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.尿激酶受体(CD87)在巨核母细胞系细胞中表达。
Thromb Haemost. 1997 Mar;77(3):540-7.
8
Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.纤溶酶原激活物抑制剂对受体结合型尿激酶的抑制作用
J Biol Chem. 1990 Jun 15;265(17):9904-8.
9
Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface.肺泡巨噬细胞尿激酶受体将酶活性定位于细胞表面。
Am J Physiol. 1990 Dec;259(6 Pt 1):L432-8. doi: 10.1152/ajplung.1990.259.6.L432.
10
The receptor for urokinase-plasminogen activator.尿激酶型纤溶酶原激活物受体
J Cell Biochem. 1986;32(3):179-86. doi: 10.1002/jcb.240320303.

引用本文的文献

1
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives.新型尿激酶型纤溶酶原激活物环素衍生物下调胶质母细胞瘤细胞的迁移、侵袭和血管生成拟态
Cells. 2025 Feb 12;14(4):259. doi: 10.3390/cells14040259.
2
αV-Integrin-Dependent Inhibition of Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry by the uPAcyclin Decapeptide.尿激酶环十肽通过αV整合素依赖性途径抑制胶质母细胞瘤细胞的迁移、侵袭和血管生成拟态
Cancers (Basel). 2023 Sep 28;15(19):4775. doi: 10.3390/cancers15194775.
3
Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.
神经血管和神经退行性疾病中的纤溶酶原激活剂
Int J Mol Sci. 2021 Apr 22;22(9):4380. doi: 10.3390/ijms22094380.
4
Breast Tumor Cell Invasion and Pro-Invasive Activity of Cancer-Associated Fibroblasts Co-Targeted by Novel Urokinase-Derived Decapeptides.新型尿激酶衍生十肽共同靶向的乳腺肿瘤细胞侵袭及癌相关成纤维细胞的促侵袭活性
Cancers (Basel). 2020 Aug 24;12(9):2404. doi: 10.3390/cancers12092404.
5
Fibroblast growth factor-2 did not restore plasminogen system activity in endothelial cells on glycated collagen.成纤维细胞生长因子-2不能恢复糖基化胶原蛋白上内皮细胞中的纤溶酶原系统活性。
Biochem Biophys Rep. 2015 Sep 3;4:104-110. doi: 10.1016/j.bbrep.2015.09.001. eCollection 2015 Dec.
6
Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.一种针对表皮生长因子受体的具有增强抗肿瘤效力的靶向选择性激活抗体的产生与表征。
MAbs. 2015;7(2):440-50. doi: 10.1080/19420862.2015.1008352.
7
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.脂筏:用于血管组织的整合平台,提供治疗机会。
Cell Mol Life Sci. 2015 Apr;72(8):1537-57. doi: 10.1007/s00018-014-1814-x. Epub 2015 Jan 1.
8
Induction of brain microvascular endothelial cell urokinase expression by Cryptococcus neoformans facilitates blood-brain barrier invasion.新型隐球菌诱导脑微血管内皮细胞尿激酶表达促进血脑屏障侵袭。
PLoS One. 2012;7(11):e49402. doi: 10.1371/journal.pone.0049402. Epub 2012 Nov 8.
9
Characterization of plasminogen binding to NB4 promyelocytic cells using monoclonal antibodies against receptor-induced binding sites in cell-bound plasminogen.使用针对细胞结合型纤溶酶原中受体诱导结合位点的单克隆抗体对纤溶酶原与NB4早幼粒细胞的结合进行表征。
J Biomed Biotechnol. 2012;2012:984589. doi: 10.1155/2012/984589. Epub 2012 Oct 14.
10
VEGF-initiated angiogenesis and the uPA/uPAR system.VEGF 引发的血管生成和 uPA/uPAR 系统。
Cell Adh Migr. 2012 Nov-Dec;6(6):535-615. doi: 10.4161/cam.22243. Epub 2012 Oct 17.